RhumbLine Advisers
EXAS

RhumbLine Advisers’s Exact Sciences EXAS Stock Holding History

RhumbLine Advisers’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-173,269
Closed -$17.6M – 4122
2025
Q4 		$17.6M Sell
173,269
-631
-0.4% -$50.7K 0.01% 771
2025
Q3 		$9.51M Sell
173,900
-1,790
-1% -$89.4K 0.01% 1102
2025
Q2 		$9.34M Sell
175,690
-45,611
-21% -$2.32M 0.01% 1081
2025
Q1 		$9.58M Buy
221,301
+3,873
+2% +$196K 0.01% 1031
2024
Q4 		$12.2M Sell
217,428
-5,997
-3% -$373K 0.01% 962
2024
Q3 		$15.2M Buy
223,425
+1,114
+0.5% +$62.9K 0.01% 873
2024
Q2 		$9.39M Sell
222,311
-222
-0.1% -$12.2K 0.01% 1056
2024
Q1 		$15.4M Sell
222,533
-2,554
-1% -$162K 0.01% 832
2023
Q4 		$16.7M Sell
225,087
-1,338
-0.6% -$87.7K 0.02% 772
2023
Q3 		$15.4M Sell
226,425
-2,828
-1% -$240K 0.02% 762
2023
Q2 		$21.5M Buy
229,253
+29,859
+15% +$2.33M 0.02% 610
2023
Q1 		$13.5M Buy
199,394
+2,575
+1% +$166K 0.02% 813
2022
Q4 		$9.74M Buy
196,819
+10,544
+6% +$431K 0.01% 957
2022
Q3 		$6.05M Buy
186,275
+9,650
+5% +$398K 0.01% 1124
2022
Q2 		$6.96M Buy
176,625
+15,448
+10% +$826K 0.01% 1087
2022
Q1 		$11.3M Sell
161,177
-6,070
-4% -$444K 0.01% 889
2021
Q4 		$13M Buy
167,247
+3,786
+2% +$334K 0.02% 843
2021
Q3 		$15.6M Sell
163,461
-2,215
-1% -$234K 0.02% 724
2021
Q2 		$20.6M Buy
165,676
+10,237
+7% +$1.22M 0.03% 588
2021
Q1 		$20.5M Sell
155,439
-5,932
-4% -$812K 0.03% 569
2020
Q4 		$21.4M Sell
161,371
-2,545
-2% -$308K 0.03% 513
2020
Q3 		$16.7M Sell
163,916
-7,854
-5% -$678K 0.03% 549
2020
Q2 		$14.9M Buy
171,770
+26,714
+18% +$2.13M 0.02% 579
2020
Q1 		$8.41M Sell
145,056
-78
-0.1% -$6.33K 0.02% 739
2019
Q4 		$13.4M Buy
145,134
+14,570
+11% +$1.28M 0.02% 671
2019
Q3 		$11.8M Sell
130,564
-1,412
-1% -$161K 0.02% 698
2019
Q2 		$15.6M Buy
131,976
+8,415
+7% +$848K 0.03% 545
2019
Q1 		$10.7M Buy
123,561
+272
+0.2% +$23.2K 0.02% 728
2018
Q4 		$7.78M Sell
123,289
-5,763
-4% -$396K 0.02% 843
2018
Q3 		$10.2M Sell
129,052
-2,384
-2% -$155K 0.02% 671
2018
Q2 		$7.86M Buy
131,436
+14,972
+13% +$806K 0.02% 799
2018
Q1 		$4.7M Sell
116,464
-5,388
-4% -$263K 0.01% 1080
2017
Q4 		$6.4M Sell
121,852
-19,115
-14% -$1.02M 0.01% 917
2017
Q3 		$6.64M Buy
140,967
+10,246
+8% +$412K 0.01% 863
2017
Q2 		$4.62M Buy
130,721
+1,511
+1% +$46.6K 0.01% 1049
2017
Q1 		$3.05M Buy
129,210
+2,552
+2% +$50.6K 0.01% 1306
2016
Q4 		$1.69M Buy
126,658
+10,240
+9% +$165K ﹤0.01% 1548
2016
Q3 		$2.16M Buy
116,418
+10,330
+10% +$182K 0.01% 1351
2016
Q2 		$1.3M Buy
106,088
+5,374
+5% +$40.5K ﹤0.01% 1625
2016
Q1 		$679K Buy
100,714
+485
+0.5% +$3.1K ﹤0.01% 2025
2015
Q4 		$925K Buy
100,229
+7,595
+8% +$70.6K ﹤0.01% 1864
2015
Q3 		$1.67M Buy
92,634
+7,514
+9% +$173K 0.01% 1431
2015
Q2 		$2.53M Sell
85,120
-2,245
-3% -$56.4K 0.01% 1243
2015
Q1 		$1.92M Buy
87,365
+15,430
+21% +$391K 0.01% 1433
2014
Q4 		$1.97M Sell
71,935
-2,420
-3% -$58.9K 0.01% 1359
2014
Q3 		$1.44M Sell
74,355
-345
-0.5% -$6.33K ﹤0.01% 1531
2014
Q2 		$1.27M Buy
74,700
+9,090
+14% +$125K ﹤0.01% 1675
2014
Q1 		$930K Sell
65,610
-2,620
-4% -$35.4K ﹤0.01% 1849
2013
Q4 		$798K Buy
68,230
+1,300
+2% +$14.9K ﹤0.01% 1964
2013
Q3 		$790K Sell
66,930
-21
-0% -$269 ﹤0.01% 1935
2013
Q2 		$931K Buy
+66,951
New +$727K ﹤0.01% 1807

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

RhumbLine Advisers's EXAS Position: Q1 2026 in Review

RhumbLine Advisers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 173,269 shares — an estimated $17.6M sold.

RhumbLine Advisers first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $21.5M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • RhumbLine Advisers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • RhumbLine Advisers sold 173,269 Exact Sciences shares in Q1 2026, an estimated $17.6M.
  • RhumbLine Advisers first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • RhumbLine Advisers's Exact Sciences position peaked at $21.5M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.